Bed Bath & Beyond

Citigroup has raised the price target on Bed Bath & Beyond (NASDAQ: BBBY) from $65 to $67 and maintains its Buy rating.

JP Morgan has raised the price target on Bed Bath & Beyond (NASDAQ: BBBY) from $59 to $62 and maintains its Neutral rating.

Goldman Sachs has raised the price target on Bed Bath & Beyond (NASDAQ: BBBY) from $60 to $63 and maintains its Neutral rating.

Wedbush Securities has raised the price target on Bed Bath & Beyond (NASDAQ: BBBY) from $63 to $67 and maintains its Outperform rating.

Deutsche Bank made a number of updates in a research report published today. Biogen Idec (NASDAQ: BIIB) had its rating upgraded from Hold to Buy. At the same time, Deutsche Bank raised its price target on the company's stock from $106 to $129. In the report, Deutsche Bank states, "Upgrading to...

Goldman Sachs has changed price targets on the following companies: Advance Auto Parts (NYSE: AAP) From $70.00 to $67.00 Bed, Bath & Beyond (NASDAQ: BBBY) From $62.00 to $60.00 Dick's Sporting Goods (NYSE: DKS) From $46.00 to $45.00 Genuine Parts Company (NYSE: GPC) From $52.00 to $51.00...

Citi released a report detailing its meeting with Bed Bath & Beyond (NASDAQ: BBBY) CEO, Steven Temares, and CFO, Eugene Castagna, which took place April 21st. Citi extracted some key information and provided insight into the management team at Bed Bath & Beyond including secrets to success...

Citigroup has raised the price target on Bed Bath & Beyond (NASDAQ: BBBY) from $62 to $65 and maintains its Buy rating.

Gilford Securities is out with its report today on Bed Bath & Beyond (NASDAQ: BBBY), reiterating Buy after strong SSS in 4Q10. In a note to clients, Gilford Securities writes, "An 8.5% same-store sales gain for 4Q/F10 came on top of an 11.5% gain a year ago, and compared with guidance for a...

Sterne Agee is out with its report today on Bed Bath & Beyond (NASDAQ: BBBY), maintaining Neutral. In a note to clients, Sterne Agee writes, "While we continue to view BBBY as a strong and consistent operator with viable long-term growth prospects, we note that potential for operating margin...

According to Sterne Agee, Bed Bath & Beyond (NASDAQ: BBBY) posted another impressive beat, with Q4 EPS of $1.12 (vs. $0.86 LY), well above our estimate of $0.96 and FC of $0.97, both of which were above the high end of the $0.91-$0.95 guidance range. Sterne Agee reported that SSS gained a...

J.P. Morgan is raising its PT on shares of Bed Bath & Beyond, Inc. (NASDAQ: BBBY). “BBBY reported a very impressive end to its FY end (February) with 4Q earnings growth of 30% and same-store sales of 8.5% vs. 3.0%E,” J.P. Morgan writes. “Based on this momentum and the flowthrough effect on our...

Wedbush is out with its report today on Bed Bath & Beyond (NASDAQ: BBBY), raising its price target from $58 to $63. In a note to clients, Wedbush writes, "Raising our price target to $63 (from $58), which assumes BBBY should trade at 16x our revised 2011 EPS estimate of $3.48, plus nearly $8...

According to Citi, Bed Bath & Beyond (NASDAQ: BBBY) is reporting 4Q results. Citi reported that Bed Bath & Beyond plans to report Q4'11 earnings today at 4:15pm with a conference call at 5pm EST. The dial in number is 1-800-281-7973. “Our $59 target price is based on a simple average of...

Oppenheimer has downgraded Bed Bath & Beyond (NASDAQ: BBBY) from Outperform to Perform and has lowered the price target from $54 to $51.